Academic background&position
data loading...
Major papers
1. [SCIE] Tau acetylation at K280 regulates tau phosphorylation [INTERNATIONAL JOURNAL OF NEUROSCIENCE] - 2023-12-01
2. [SCIE] Amphiregulin normalizes altered circuit connectivity for social dominance of the CRTC3 knockout mouse [MOLECULAR PSYCHIATRY] - 2023-11-01
3. [SCIE] Neuronal MHC-I complex is destabilized by amyloid-β and its implications in Alzheimer's disease [Cell and Bioscience] - 2023-09-29
4. [SCIE] Monoclonal antibody Y01 prevents tauopathy progression induced by lysine 280-acetylated tau in cell and mouse models [JOURNAL OF CLINICAL INVESTIGATION] - 2023-04-17
5. [SCIE] TLQP-21 mediated activation of microglial BV2 cells promotes clearance of extracellular fibril amyloid-beta [BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS] - 2020-04-09
Offices
Dementia Biopharmaceuticals Development Department
Our lab develops biopharmaceuticals such as antibodies and peptides for the treatment and diagnosis of Alzheimer's disease.
From basic research on neuroscience to the development of treatment for neurological diseases,
we hope that many students who want to maximize their abilities will apply to our lab.
Faculty/Research
